Common Stock, Shares Authorized of bluebird bio, Inc. from 31 Dec 2012 to 31 Mar 2025

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
bluebird bio, Inc. quarterly Common Stock, Shares Authorized in shares history and change rate from 31 Dec 2012 to 31 Mar 2025.
  • bluebird bio, Inc. Common Stock, Shares Authorized for the quarter ending 31 Mar 2025 was 250,000,000, unchanged year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Change (%)

bluebird bio, Inc. Quarterly Common Stock, Shares Authorized (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2025 250,000,000 0 0% 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 250,000,000 0 0% 31 Dec 2024 10-Q 14 May 2025 2025 Q1
Q3 2024 250,000,000 0 0% 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 250,000,000 0 0% 30 Jun 2024 10-Q 27 Sep 2024 2024 Q2
Q1 2024 250,000,000 +125,000,000 +100% 31 Mar 2024 10-Q 13 Sep 2024 2024 Q1
Q4 2023 250,000,000 +125,000,000 +100% 31 Dec 2023 10-K 27 Mar 2025 2024 FY
Q3 2023 250,000,000 +125,000,000 +100% 30 Sep 2023 10-K 13 Sep 2024 2023 FY
Q2 2023 250,000,000 +125,000,000 +100% 30 Jun 2023 10-K 13 Sep 2024 2023 FY
Q1 2023 125,000,000 0 0% 31 Mar 2023 10-K 13 Sep 2024 2023 FY
Q4 2022 125,000,000 0 0% 31 Dec 2022 10-K 13 Sep 2024 2023 FY
Q3 2022 125,000,000 0 0% 30 Sep 2022 10-K 13 Sep 2024 2023 FY
Q2 2022 125,000,000 0 0% 30 Jun 2022 10-K 13 Sep 2024 2023 FY
Q1 2022 125,000,000 0 0% 31 Mar 2022 10-K 13 Sep 2024 2023 FY
Q4 2021 125,000,000 0 0% 31 Dec 2021 10-K 29 Mar 2023 2022 FY
Q3 2021 125,000,000 0 0% 30 Sep 2021 10-Q 05 Nov 2021 2021 Q3
Q2 2021 125,000,000 0 0% 30 Jun 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 125,000,000 0 0% 31 Mar 2021 10-Q 05 May 2021 2021 Q1
Q4 2020 125,000,000 0 0% 31 Dec 2020 10-K 04 Mar 2022 2021 FY
Q3 2020 125,000,000 0 0% 30 Sep 2020 10-Q 04 Nov 2020 2020 Q3
Q2 2020 125,000,000 0 0% 30 Jun 2020 10-Q 05 Aug 2020 2020 Q2
Q1 2020 125,000,000 0 0% 31 Mar 2020 10-Q 11 May 2020 2020 Q1
Q4 2019 125,000,000 0 0% 31 Dec 2019 10-K 23 Feb 2021 2020 FY
Q3 2019 125,000,000 0 0% 30 Sep 2019 10-Q 31 Oct 2019 2019 Q3
Q2 2019 125,000,000 0 0% 30 Jun 2019 10-Q 01 Aug 2019 2019 Q2
Q1 2019 125,000,000 0 0% 31 Mar 2019 10-Q 03 May 2019 2019 Q1
Q4 2018 125,000,000 0 0% 31 Dec 2018 10-K 18 Feb 2020 2019 FY
Q3 2018 125,000,000 0 0% 30 Sep 2018 10-Q 01 Nov 2018 2018 Q3
Q2 2018 125,000,000 0 0% 30 Jun 2018 10-Q 02 Aug 2018 2018 Q2
Q1 2018 125,000,000 0 0% 31 Mar 2018 10-Q 02 May 2018 2018 Q1
Q4 2017 125,000,000 0 0% 31 Dec 2017 10-K 21 Feb 2019 2018 FY
Q3 2017 125,000,000 0 0% 30 Sep 2017 10-Q 01 Nov 2017 2017 Q3
Q2 2017 125,000,000 0 0% 30 Jun 2017 10-Q 02 Aug 2017 2017 Q2
Q1 2017 125,000,000 0 0% 31 Mar 2017 10-Q 03 May 2017 2017 Q1
Q4 2016 125,000,000 0 0% 31 Dec 2016 10-K 21 Feb 2018 2017 FY
Q3 2016 125,000,000 0 0% 30 Sep 2016 10-Q 02 Nov 2016 2016 Q3
Q2 2016 125,000,000 0 0% 30 Jun 2016 10-Q 03 Aug 2016 2016 Q2
Q1 2016 125,000,000 0 0% 31 Mar 2016 10-Q 04 May 2016 2016 Q1
Q4 2015 125,000,000 0 0% 31 Dec 2015 10-K 22 Feb 2017 2016 FY
Q3 2015 125,000,000 0 0% 30 Sep 2015 10-Q 05 Nov 2015 2015 Q3
Q2 2015 125,000,000 0 0% 30 Jun 2015 10-Q 07 Aug 2015 2015 Q2
Q1 2015 125,000,000 0 0% 31 Mar 2015 10-Q 06 May 2015 2015 Q1
Q4 2014 125,000,000 0 0% 31 Dec 2014 10-K 25 Feb 2016 2015 FY
Q3 2014 125,000,000 0 0% 30 Sep 2014 10-Q 12 Nov 2014 2014 Q3
Q2 2014 125,000,000 0 0% 30 Jun 2014 10-Q 12 Aug 2014 2014 Q2
Q1 2014 125,000,000 31 Mar 2014 10-Q 13 May 2014 2014 Q1
Q4 2013 125,000,000 +103,911,000 +493% 31 Dec 2013 10-K 25 Feb 2015 2014 FY
Q3 2013 125,000,000 30 Sep 2013 10-Q 14 Nov 2013 2013 Q3
Q2 2013 125,000,000 30 Jun 2013 10-Q 14 Aug 2013 2013 Q2
Q4 2012 21,089,000 31 Dec 2012 10-K 05 Mar 2014 2013 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.